[Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000652:urine*; D004407:Dysgerminoma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008297:Male; D013724:Teratoma / Q000188:drug therapy* / Q000378:metabolism; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D000509:alpha-Fetoproteins / Q000032:analysis*
D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase
Izuchenie nekotorykh markerov (alpha-fetoprotein, khorionicheskiĭ gonadotropin, laktatdegidrogenaza) pri khimioterapii zlokachestvennykh opukholeĭ iaichka.